A Randomized, Open Label, Single Dose, 2-way Crossover Clinical Trial to Evaluate the Pharmacokinetic Characteristics and Safety Between HCP1902 and RLD2007/RLD2008 in Healthy Volunteers
Latest Information Update: 08 Aug 2022
At a glance
- Drugs HCP 1902 (Primary)
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 31 Jul 2022 Status changed from active, no longer recruiting to completed.
- 08 Jul 2021 New trial record